Actos May Lower Heart Disease Risk In Diabetics With Kidney Disease

December 15, 2007 by MedHeadlines  
Filed under Diabetes, Drugs, Heart Disease, Renal Disease

actosMed Headlines - A study conducted in Cologne, Germany, concluded that pioglitazone (Actos) may lower the risk of serious cardiovascular events for diabetic patients who have kidney disease. The study, which is featured in the January issue of the Journal of the American Society of Nephrology, was conducted by Dr. Chistian A. Schneider of the University of Cologne. Read more

-->

Polls

  • Should healthcare professionals, who oppose abortion for moral reasons, be forced to perform the procedure anyway?

    View Results

    Loading ... Loading ...

Editor's Picks

alt text Did Marrow Transplant Cure AIDS?

That’s the question abuzz in the medical community as doctors around the globe...

alt text Fan In Baby’s Room Reduces Risk of SIDS

One of the most heartbreaking and frustrating diagnoses discussed today is that of...

alt text Top Economist Says McCain’s Health Plan Better for More Americans

In a Wall Street Journal (WSJ) opinion piece, one of the nation’s top economists...

More Editor's Picks
    End, comment out -->